WO2021069736A1
|
|
New carbazole derivatives sensitizing cells to anti-cancer agents
|
WO2021064095A1
|
|
Biocompatible nucleic acids for digital data storage
|
WO2021058503A1
|
|
Method for identifying gene products involved in incomplete response of drug sensitive cell populations
|
WO2021037935A1
|
|
Method and device for the optical characterisation of particles
|
WO2021005210A1
|
|
Chemically-modified adeno-associated virus
|
WO2021001363A1
|
|
Lithography production method
|
WO2020260203A1
|
|
Microfluid analysis method and device for quantifying soluble gaseous polutants in water
|
WO2020254654A1
|
|
Fluorescent complexes comprising two rhodamine derivatives and a nucleic acid molecule
|
US2020377801A1
|
|
Tube for a steam cracking furnace having a segment with an elliptical or lobed cross section
|
WO2020239947A1
|
|
Prognosis method of leukemia
|
WO2020239949A1
|
|
Method for identifying ubiquitin and ubiquitin-like enzyme activities
|
WO2020239876A1
|
|
Method of digital multiplex detection and/or quantification of biomolecules and use thereof
|
WO2020239874A1
|
|
Digital biomolecules detection and/or quantification using isothermal amplification
|
WO2020229678A1
|
|
Biomarker for assessment of spinal cord injury
|
WO2020208425A1
|
|
A stator winding arrangement
|
WO2020193499A1
|
|
Hall effect ion ejection device
|
WO2020188103A1
|
|
Amphiphysin / bin1 for the treatment of autosomal dominant centronuclear myopathy
|
WO2020187850A1
|
|
Mutant vsv ectodomain polypeptide and uses thereof
|
US10917109B1
|
|
Methods for storing digital data as, and for transforming digital data into, synthetic DNA
|
WO2020161440A1
|
|
New water-soluble nanocrystal synthesis process and automated system
|